Professor Oriana Ciani

  • Affiliate (School of Health & Wellbeing)

email: Oriana.Ciani@glasgow.ac.uk

MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Berkeley Square, 99 Berkeley Street, G3 7HR

Publications

List by: Type | Date

Jump to: 2022
Number of items: 9.

2022

Ciani, O., Manyara, A. M. , Chen, A.-W. and Taylor, R. S. (2022) Surrogate endpoints in trials: a call for better reporting. Trials, 23, 991. (doi: 10.1186/s13063-022-06904-7) (PMID:36503559) (PMCID:PMC9743760)

Ciani, O., Manyara, A. M. and Taylor, R. S. (2022) Surrogate endpoints in cardio-thoracic trials: a call for better reporting and improved interpretation of trial findings. European Journal of Cardio-Thoracic Surgery, 62(4), ezac449. (doi: 10.1093/ejcts/ezac449) (PMID:36112148)

Manyara, A. , Davies, P., Stewart, D., Wells, V. , Weir, C., Young, A., Taylor, R. and Ciani, O. (2022) Scoping and targeted reviews to support development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: protocol. BMJ Open, 12(10), e062798. (doi: 10.1136/bmjopen-2022-062798) (PMID:36229145) (PMCID:PMC9562307)

Manyara, A. M. et al. (2022) Protocol for the development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: SPIRIT-SURROGATE and CONSORT-SURROGATE. BMJ Open, 12(10), e064304. (doi: 10.1136/bmjopen-2022-064304) (PMID:36220321) (PMCID:PMC9557267)

Ciani, O., Grigore, B. and Taylor, R. S. (2022) Development of a framework and decision tool for the evaluation of health technologies based on surrogate endpoint evidence. Health Economics, 31(S1), pp. 44-72. (doi: 10.1002/hec.4524) (PMID:35608044) (PMCID:PMC9546394)

Ciani, O., Manyara, A. M. and Taylor, R. S. (2022) Need for better reporting of trials with surrogate endpoints – SPIRIT|CONSORT-SURROGATE extensions. Journal of Epidemiology and Community Health, 76(9), pp. 769-770. (doi: 10.1136/jech-2022-219294) (PMID:35750481) (PMCID:PMC9380472)

Ciani, O., Manyara, A. M. and Taylor, R. S. (2022) Surrogate endpoints in trials – a call for better reporting. British Medical Journal, 378, o1912. (doi: 10.1136/bmj.o1912) (PMID:35905986)

Manyara, A. M. , Ciani, O. and Taylor, R. S. (2022) A call for better reporting of trials using surrogate primary endpoints. Alzheimer's and Dementia: Translational Research and Clinical Interventions, 8(1), e12340. (doi: 10.1002/trc2.12340) (PMID:35910671) (PMCID:PMC9323346)

Manyara, A. M. , Ciani, O. and Taylor, R. S. (2022) Reply to Commentary by Cummings (2022): Surrogate endpoints extend beyond biomarkers. Alzheimer's and Dementia, 8(1), e12344. (doi: 10.1002/trc2.12344) (PMID:35910664) (PMCID:PMC9323349)

This list was generated on Sun Feb 5 18:20:31 2023 GMT.
Jump to: Articles
Number of items: 9.

Articles

Ciani, O., Manyara, A. M. , Chen, A.-W. and Taylor, R. S. (2022) Surrogate endpoints in trials: a call for better reporting. Trials, 23, 991. (doi: 10.1186/s13063-022-06904-7) (PMID:36503559) (PMCID:PMC9743760)

Ciani, O., Manyara, A. M. and Taylor, R. S. (2022) Surrogate endpoints in cardio-thoracic trials: a call for better reporting and improved interpretation of trial findings. European Journal of Cardio-Thoracic Surgery, 62(4), ezac449. (doi: 10.1093/ejcts/ezac449) (PMID:36112148)

Manyara, A. , Davies, P., Stewart, D., Wells, V. , Weir, C., Young, A., Taylor, R. and Ciani, O. (2022) Scoping and targeted reviews to support development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: protocol. BMJ Open, 12(10), e062798. (doi: 10.1136/bmjopen-2022-062798) (PMID:36229145) (PMCID:PMC9562307)

Manyara, A. M. et al. (2022) Protocol for the development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: SPIRIT-SURROGATE and CONSORT-SURROGATE. BMJ Open, 12(10), e064304. (doi: 10.1136/bmjopen-2022-064304) (PMID:36220321) (PMCID:PMC9557267)

Ciani, O., Grigore, B. and Taylor, R. S. (2022) Development of a framework and decision tool for the evaluation of health technologies based on surrogate endpoint evidence. Health Economics, 31(S1), pp. 44-72. (doi: 10.1002/hec.4524) (PMID:35608044) (PMCID:PMC9546394)

Ciani, O., Manyara, A. M. and Taylor, R. S. (2022) Need for better reporting of trials with surrogate endpoints – SPIRIT|CONSORT-SURROGATE extensions. Journal of Epidemiology and Community Health, 76(9), pp. 769-770. (doi: 10.1136/jech-2022-219294) (PMID:35750481) (PMCID:PMC9380472)

Ciani, O., Manyara, A. M. and Taylor, R. S. (2022) Surrogate endpoints in trials – a call for better reporting. British Medical Journal, 378, o1912. (doi: 10.1136/bmj.o1912) (PMID:35905986)

Manyara, A. M. , Ciani, O. and Taylor, R. S. (2022) A call for better reporting of trials using surrogate primary endpoints. Alzheimer's and Dementia: Translational Research and Clinical Interventions, 8(1), e12340. (doi: 10.1002/trc2.12340) (PMID:35910671) (PMCID:PMC9323346)

Manyara, A. M. , Ciani, O. and Taylor, R. S. (2022) Reply to Commentary by Cummings (2022): Surrogate endpoints extend beyond biomarkers. Alzheimer's and Dementia, 8(1), e12344. (doi: 10.1002/trc2.12344) (PMID:35910664) (PMCID:PMC9323349)

This list was generated on Sun Feb 5 18:20:31 2023 GMT.